Skip to content

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00233922
Enrollment
80
Registered
2005-10-06
Start date
2004-07-31
Completion date
2007-07-31
Last updated
2008-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orbital Fractures, Orbital Trauma

Keywords

orbit, orbital, trauma, fractures, facial

Brief summary

Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months. CT scan of the orbits are performed preop, 6 months & 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.

Detailed description

Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months. CT scan of the orbits are performed preop, 6 months & 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.

Interventions

DEVICEOsteosheet(r)

Sponsors

National Healthcare Group, Singapore
CollaboratorOTHER_GOV
National University Hospital, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* age: 20 - 70 years facial trauma with orbital fractures

Exclusion criteria

* No other coexistent conditions eg. diabetes, heart disease, etc

Design outcomes

Primary

MeasureTime frame
visual acuity
Enophthalmos
Diplopia
Cosmetic appearance

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026